New frontiers in therapeutic resistance in cancer.
Détails
ID Serval
serval:BIB_4C2CC1085D86
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
New frontiers in therapeutic resistance in cancer.
Périodique
Expert Review of Anticancer Therapy
ISSN
1744-8328 (Electronic)
ISSN-L
1473-7140
Statut éditorial
Publié
Date de publication
2012
Volume
12
Numéro
7
Pages
877-879
Langue
anglais
Notes
Publication types: Congresses
WOS Document Type: Review
WOS Document Type: Review
Résumé
Despite advances in personalized medicine and targeted therapies, therapeutic resistance remains a persistent dilemma encountered by clinicians, scientists and patients. In this article we summarize the highlights of the third Quebec Conference on Therapeutic Resistance in Cancer. This unique meeting provided researchers and clinicians with insights into: intrinsic and acquired resistance; tumor heterogeneity; complexities of biomarker-driven trials; challenges of 'omics data analysis; and models of clinical applications of personalized medicine. Emphasized throughout the conference was the importance of collaborations - between industry and academia, and between basic researchers and clinicians - so that therapeutic resistance can be studied where it matters most, in patients.
Pubmed
Web of science
Création de la notice
11/10/2012 16:54
Dernière modification de la notice
20/08/2019 14:00